Reverse Acquisition (Details Narrative) (10-K) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Oct. 04, 2017 |
Sep. 29, 2017 |
Dec. 31, 2017 |
Jun. 30, 2018 |
Dec. 31, 2016 |
|
| Common stock shares issued | 35,272,626 | 38,674,265 | 31,745,242 | ||
| Common stock shares outstanding | 35,272,626 | 38,674,265 | 31,745,242 | ||
| Promet Therapeutics LLC [Member] | |||||
| General and administrative expense | $ 58,763 | ||||
| Parent Company [Member] | |||||
| Business acquisition acquired value | $ 1,017,342 | ||||
| Business acquisition exchange percentage | 90.00% | ||||
| Business acquisition of common stock issued shares | 222,217,112 | ||||
| Stock issued during reserve split | 31,745,242 | 1,850,625 | 35,272,626 | ||
| Common stock shares issued | 246,907,902 | ||||
| Common stock shares outstanding | 246,907,902 |
| X | ||||||||||
- Definition Business acquisition exchange percentage. No definition available.
|
| X | ||||||||||
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of a stock split. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|